Compound information
- Natural Products
- ZC3037438
- Molecular Formula
- C18H30O3
- Molecular Weight
- 294.21949482 g/mol
- Structure
-
- IUPAC Name
- (9Z,11E)-13-oxooctadeca-9,11-dienoic acid
- InChI
- InChI=1S/C18H30O3/c1-2-3-11-14-17(19)15-12-9-7-5-4-6-8-10-13-16-18(20)21/h7,9,12,15H,2-6,8,10-11,13-14,16H2,1H3,(H,20,21)/b9-7-,15-12+
- InChI Key
- JHXAZBBVQSRKJR-BSZOFBHHSA-N
- SMILES
- CCCCCC(=O)/C=C/C=C\CCCCCCCC(=O)O
- Source
- ZINC000004655398
Warheads
- Michael Acceptor
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 21 | Ring Count | 0 |
| Heteroatom Count | 3 | Rotatable Bond Count | 14 |
| Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 54.37 Å2 | LogP | 4.724 |
| LogS | -3.557 | LogD | 2.957 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.023 | Pgp substrate | 0.0 |
| HIA | 0.967 | F20 % | 0.987 |
| F30 % | 0.206 | Caco-2 | -4.418 |
| MDCK | -4.518 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.974 | PPB | 97.464 |
| VD | 0.416 | Fu | 1.171 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.102 | CYP1A2 substrate | 0.267 |
| CYP2A6 substrate | 0.315 | CYP2B6 substrate | 0.413 |
| CYP2C19 inhibitor | 0.029 | CYP2C19 substrate | 0.259 |
| CYP2C8 substrate | 0.482 | CYP2C9 inhibitor | 0.198 |
| CYP2C9 substrate | 0.019 | CYP2D6 inhibitor | 0.417 |
| CYP2D6 substrate | 0.109 | CYP2E1 substrate | 0.25 |
| CYP3A4 inhibitor | 0.035 | CYP3A4 substrate | 0.017 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.91 | CL | 2.31 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.618 | Hepatotoxicity | 0.926 |
| Mutagenicity | 0.018 | Rat Oral Acute Toxicity | 0.003 |
| FDAMDD | 0.173 | Skin Sensitization | 0.995 |
| Carcinogenicity | 0.733 | Eye Corrosion | 0.113 |
| Eye Irritation | 0.962 | Respiratory Toxicity | 0.074 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.587 | IGC50 | 4.817 |
| LC50FM | 4.53 | LC50DM | 5.476 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.17 | NR-AR-LBD | 0.225 |
| NR-AhR | 0.006 | NR-Aromatase | 0.029 |
| NR-ER | 0.179 | NR-ER-LBD | 0.252 |
| NR-PPAR-gamma | 0.358 | SR-ARE | 0.13 |
| SR-ATAD5 | 0.18 | SR-HSE | 0.024 |
| SR-MMP | 0.008 | SR-p53 | 0.156 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.